# NYU Langone Reproductive Specialists of New York - Inspection Records

Source: https://www.keypedia.com/companies/nyu-langone-reproductive-specialists-of-new-york/52eb9f0c-c77b-402f-814f-99231ae84dd1

> Inspection records and compliance data for NYU Langone Reproductive Specialists of New York in Mineola, New York. Access full analysis and detailed observations.

---

## Details

- Name: NYU Langone Reproductive Specialists of New York
- FEI Number: 3003972384
- City: Mineola
- State: New York
- Country Name: United States
- Address Line 1: 200 Old Country Rd Ste 330
- Zip Code: 11501

## Related Documents

- [FDA Inspection 1304730 - NYU Langone Reproductive Specialists of New York - 2026-02-27](https://www.keypedia.com/records/fda_inspections/nyu-langone-reproductive-specialists-of-new-york/346e4d76-8039-4b73-8d83-bb7d1ebf7e70) — source: FDA, date: February 27, 2026
- [FDA Inspection 1304730 - NYU Langone Reproductive Specialists of New York - 2026-02-27](https://www.keypedia.com/records/fda_inspections/nyu-langone-reproductive-specialists-of-new-york/2e23df8a-2ce3-46bb-abdf-4e4928ff3993) — classification: No Action Indicated (NAI), source: FDA, date: February 27, 2026
- [FDA Inspection 1199834 - NYU Langone Reproductive Specialists of New York - 2023-03-13](https://www.keypedia.com/records/fda_inspections/nyu-langone-reproductive-specialists-of-new-york/8c78784a-c104-46aa-809e-e58951cd924d) — classification: No Action Indicated (NAI), source: FDA, date: March 13, 2023
- [FDA Inspection 1199834 - NYU Langone Reproductive Specialists of New York - 2023-03-13](https://www.keypedia.com/records/fda_inspections/nyu-langone-reproductive-specialists-of-new-york/a75efe50-33c0-4b36-b493-ded17203eae7) — classification: No Action Indicated (NAI), source: FDA, date: March 13, 2023
- [FDA Inspection 1199834 - NYU Langone Reproductive Specialists of New York - 2023-03-13](https://www.keypedia.com/records/fda_inspections/nyu-langone-reproductive-specialists-of-new-york/e9c7cdf8-582a-4d78-92b2-45d6ee20b8fa) — classification: No Action Indicated (NAI), source: FDA, date: March 13, 2023
- [483 - NYU Langone Reproductive Specialists of New York - 2021-09-30](https://www.keypedia.com/records/483/nyu-langone-reproductive-specialists-of-new-york/2f897fd9-5785-4e4e-9b94-1ed12330a3b7) — source: FDA, date: September 30, 2021
- [FDA Inspection 1153269 - NYU Langone Reproductive Specialists of New York - 2021-09-30](https://www.keypedia.com/records/fda_inspections/nyu-langone-reproductive-specialists-of-new-york/2aba5731-6feb-466e-a4c1-bd7ca98a312d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 30, 2021
- [FDA Inspection 1153269 - NYU Langone Reproductive Specialists of New York - 2021-09-30](https://www.keypedia.com/records/fda_inspections/nyu-langone-reproductive-specialists-of-new-york/2fd0ec72-e80f-4672-9057-e118e8300a9c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 30, 2021
- [FDA Inspection 1153269 - NYU Langone Reproductive Specialists of New York - 2021-09-30](https://www.keypedia.com/records/fda_inspections/nyu-langone-reproductive-specialists-of-new-york/8e6cc78b-be74-4026-8f33-de5a97f777ac) — classification: No Action Indicated (NAI), source: FDA, date: September 30, 2021
- [483 - NYU Langone Reproductive Specialists of New York - 2020-09-25](https://www.keypedia.com/records/483/nyu-langone-reproductive-specialists-of-new-york/9ef97289-8edf-4b3c-a772-5bc49d11ba36) — source: FDA, date: September 25, 2020
- [FDA Inspection 1129967 - NYU Langone Reproductive Specialists of New York - 2020-09-25](https://www.keypedia.com/records/fda_inspections/nyu-langone-reproductive-specialists-of-new-york/11c206fc-0b4c-4146-9aa1-9051a6f0607e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 25, 2020
- [FDA Inspection 1129967 - NYU Langone Reproductive Specialists of New York - 2020-09-25](https://www.keypedia.com/records/fda_inspections/nyu-langone-reproductive-specialists-of-new-york/92082588-59e6-467c-b1ae-ac77e4650468) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 25, 2020

## Related Companies

- [Qiagen Sciences LLC](https://www.keypedia.com/companies/qiagen-sciences-llc/501f56d6-2a3c-4109-9ff2-ec1ac76e696d)
- [Merck Sharp & Dohme LLC](https://www.keypedia.com/companies/merck-sharp-dohme-llc/a46a094a-b27d-49bf-bde5-42441f92c622)
- [Artegraft, Inc.](https://www.keypedia.com/companies/artegraft-inc/ea31640f-5897-4972-8d68-16ea7ca1d8eb)
- [HTO Nevada Inc](https://www.keypedia.com/companies/hto-nevada-inc/c42bc0ec-4d68-4db5-8860-0f6c8e248c99)
- [Edwards Lifesciences, LLC](https://www.keypedia.com/companies/edwards-lifesciences-llc/33cf0071-5dab-4e01-8479-22f60c63e818)
- [Grifols Diagnostic Solutions Inc.](https://www.keypedia.com/companies/grifols-diagnostic-solutions-inc/7fe8042b-3212-4fa9-adaa-05e94b681222)
- [Artivion, Inc](https://www.keypedia.com/companies/artivion-inc/484ce438-d451-4d95-ab4c-726a2dc02c92)
- [Globus Medical, Inc.](https://www.keypedia.com/companies/globus-medical-inc/28189b72-9de1-4074-9971-5eeb3e956f43)
- [Pfizer, Inc.](https://www.keypedia.com/companies/pfizer-inc/4b87fbf2-bec7-4fde-adf0-4207cd7d93ff)
- [Sciarra Laboratories, Inc.](https://www.keypedia.com/companies/sciarra-laboratories-inc/524d2f58-5717-46af-bdb2-7289f54a823d)

## Related Officers

- [Investigator](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)